Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.07 USD
Change Today -0.08 / -3.72%
Volume 17.6K
DSKX On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 10:16 AM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

ds healthcare group inc (DSKX) Key Developments

Ds Healthcare Group, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2015

DS Healthcare Group, Inc. announced unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported GAAP net loss of $85,138 compared to $850,153 a year ago. Adjusted EBITDAS was $48,492 compared to adjusted LBITDAS of $786,845 a year ago. Net revenues were $2,803,920 up 4.4% over first quarter of 2014. Revenue growth in the first quarter was driven by higher demand for the company products both in the US and internationally.

DS Healthcare Group, Inc. announced delayed 10-Q filing

On 05/18/2015, DS Healthcare Group, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

DS Healthcare Group, Inc. Announces Changes to the Board of Directors

Effective May 5, 2015, Dr. Keith Markey resigned as director of DS Healthcare Group, Inc. Dr. Markey has not expressed any disagreement with the company on any matter relating to the Company's operations, policies or practices. Dr. Markey was a member of the company audit committee, compensation committee and nominating committee. Effective May 8, 2015, the board of directors of the company appointed Karl Sweis to fill the recently created vacancy on the company's board of directors. Mr. Sweis has been appointed to serve as the company's Compensation Committee chairman and shall also serve on the company's audit committee and nominating committee.

DS Healthcare Group, Inc. Announces Board Changes

Effective April 29, 2015 Matthew Pfeffer resigned as director of DS Healthcare Group, Inc. Mr. Pfeffer has not expressed any disagreement with the company on any matter relating to the company's operations, policies or practices. Mr. Pope, a current director of the company, has been appointed to serve as the company's Audit Committee chairman following Mr. Pfeffer's resignation. Effective April 29, 2015, the board of directors appointed Michael Pope to fill the recently created vacancy on the company's board of directors. Mr. Pope shall also serve on the company's audit, compensation and nominating committees. Mr. Pope has served as managing director of Vert Capital Corp., since October 2011.

DS Healthcare Group Regains Compliance With NASDAQ Listing Requirements

DS Healthcare Group, Inc. announced that it has regained compliance with the listing requirements of the NASDAQ Capital Market. As previously reported, on December 16, 2014, NASDAQ notified the Company that its common stock was not in listing compliance as it failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by NASDAQ's listing rules. On April 29, 2015, the Company received a notice from the NASDAQ indicating that since the closing bid price of the Company's common stock had been at $1.00 per share or greater for the last 10 consecutive business days, the Company has regained compliance with Listing Rule 5550(a)(2) and this matter is now closed.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DSKX:US $2.07 USD -0.08

DSKX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Johnson & Johnson $101.23 USD +0.10
Procter & Gamble Co/The $79.19 USD -0.20
View Industry Companies
 

Industry Analysis

DSKX

Industry Average

Valuation DSKX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.7x
Price/Book 6.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DS HEALTHCARE GROUP INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.